These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6772366)

  • 41. [Use of 5,6-trans-25-OH-cholecalciferol in patients needing dialysis with florid renal osteopathy: therapeutic management and treatment results].
    Cremer W; Graben N; Merguet P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1307-10. PubMed ID: 611841
    [No Abstract]   [Full Text] [Related]  

  • 42. Bromocriptine improves reduced libido and potency in men receiving maintenance hemodialysis.
    Muir JW; Besser GM; Edwards CR; Rees LH; Cattell WR; Ackrill P; Baker LR
    Clin Nephrol; 1983 Dec; 20(6):308-14. PubMed ID: 6357576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The effect of erythropoietin treatment on endocrine organ function in patients with terminal-stage kidney failure on hemodialysis].
    Kokot F; Wiecek A; Grzeszczak W; Klin M; Klepacka J; Lao M
    Ter Arkh; 1991; 63(6):86-9. PubMed ID: 1948756
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol.
    Chan JC; DeLuca HR
    JAMA; 1979 Mar; 241(12):1242-4. PubMed ID: 762789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between parathormone and sexual hormones in patients on haemodialysis.
    Sahovic V; Sahovic S; Grosa E; Avdic E; Helac-Cvijetic D; Kukavica N
    Med Arch; 2012; 66(3):177-80. PubMed ID: 22822618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sex hormone metabolism and sexual dysfunction in chronic kidney failure with maintenance hemodialysis therapy].
    Kinouchi T; Koide K; Shimizu N
    Nihon Rinsho; 1992 Jan; 50 Suppl():584-93. PubMed ID: 1578742
    [No Abstract]   [Full Text] [Related]  

  • 47. 1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.
    Brickman AS; Sherrard DJ; Jowsey J; Singer FR; Baylink DJ; Maloney N; Massry SG; Norman AW; Coburn JW
    Arch Intern Med; 1974 Nov; 134(5):883-8. PubMed ID: 4613310
    [No Abstract]   [Full Text] [Related]  

  • 48. Evaluation of the relationship between endogenous gonadotropins and female sexual function and psychological status in predialysis and hemodialysis patients.
    Kurdoglu Z; Usul Soyoral Y; Tasdemir M; Kurdoglu M
    Gynecol Endocrinol; 2012 Apr; 28(4):336-9. PubMed ID: 21824048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH; Goldstein DA; Massry SG
    Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
    [No Abstract]   [Full Text] [Related]  

  • 50. Sexual and gonadal functions in elderly uremic patients on hemodialysis.
    Mastrogiacomo I; De Besi L; Serafini E; La Greca G; Gasparotto ML; Lorenzi S; Zucchetta P
    J Endocrinol Invest; 1985; 8 Suppl 2():117-21. PubMed ID: 3928737
    [No Abstract]   [Full Text] [Related]  

  • 51. Sexual dysfunction in uremia.
    O'Brien KM; Rawl J; Binkley L; Stone WJ
    Proc Clin Dial Transplant Forum; 1975 Nov; 5():98-101. PubMed ID: 785469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The action of 1,25 (OH)2D3 on turnover kinetic, remodelling surfaces and structure of trabecular bone in chronic renal failure.
    Delling G; Lühmann H; Bulla M; Fuchs C; Henning HV; Jansen JL; Kohnle W; Schulz W
    Contrib Nephrol; 1980; 18():105-21. PubMed ID: 7353369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute neuroendocrine response to sexual stimulation in sexual offenders.
    Haake P; Schedlowski M; Exton MS; Giepen C; Hartmann U; Osterheider M; Flesch M; Janssen OE; Leygraf N; Krüger TH
    Can J Psychiatry; 2003 May; 48(4):265-71. PubMed ID: 12776394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maintenance of sexual function in a castrated man treated with ovarian steroids.
    Davidson JM; Camargo C; Smith ER; Kwan M
    Arch Sex Behav; 1983 Jun; 12(3):263-74. PubMed ID: 6309119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hyperprolactinemia in chronic kidney failure patients].
    Milanov S; Belovezhdov N; Gruev I; Milkov V; Neshev G
    Vutr Boles; 1983; 22(2):111-4. PubMed ID: 6659479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of oral zinc therapy on gonadal function in hemodialysis patients. A double-blind study.
    Mahajan SK; Abbasi AA; Prasad AS; Rabbani P; Briggs WA; McDonald FD
    Ann Intern Med; 1982 Sep; 97(3):357-61. PubMed ID: 7051913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of recombinant erythropoietin on sexual function in hemodialysis patients.
    Schaefer RM; Kokot F; Heidland A
    Contrib Nephrol; 1989; 76():273-81; discussion 281-2. PubMed ID: 2684527
    [No Abstract]   [Full Text] [Related]  

  • 58. The effects of bromocriptine on the sexual behaviour of hyperprolactinaemic man: a controlled case study.
    Bancroft J; O'Carroll R; McNeilly A; Shaw RW
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):131-7. PubMed ID: 6432375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endocrine factors in geriatric sexuality.
    Morley JE
    Clin Geriatr Med; 1991 Feb; 7(1):85-93. PubMed ID: 2004293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
    J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.